हाल में देखा गया

  • होम
  • स्टोरी
  • News Announcement
  • Mesco Pharmaceuticals: Board Meeting Intimation for Consider And Approve The Standalone Unaudited Financial Results For The Quarter Ended On 30Th June 2021 Along With Limited Review Reports
News Announcement

Mesco Pharmaceuticals: Board Meeting Intimation for Consider And Approve The Standalone Unaudited Financial Results For The Quarter Ended On 30Th June 2021 Along With Limited Review Reports

04-सितंबर-2021 Follow Value Research Online on Google download pdfडाउनलोड पीडीएफ़ Mesco Pharmaceuticals

MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2021 inter alia to consider and approve 1. To consider and approve the standalone unaudited financial results for the quarter ended on 30th June 2021 along with Limited Review Reports.
2. Consider matters relating to the ensuing Annual General Meeting

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan